Catalio Capital Management

Investment thesis

Thesis-driven firm (founded 2020) investing in breakthrough biomedical technology at all stages and throughout the capital structure, partnering with scientist-founders and university spinouts to build category-defining businesses. ~$2B AUM; average venture cheque reported around $15M.

Notable portfolio

Sector focus